两点法测定腺苷脱氨酶  被引量:8

DETERMINATION OF ADENOSINE DEAMINASE BY TWO-POINT ASSAY

在线阅读下载全文

作  者:马志如[1] 黄天禄[1] 陈宏础[1] 邓庆英 

机构地区:[1]重庆医科大学附一院检验科

出  处:《四川省卫生管理干部学院学报》1997年第3期131-133,共3页Journal of Sichuan Continuing Education College of Medical Sciences

摘  要:目的:基于文献报道法建立一种两点法测定腺苷脱氨酶(ADA)活性的方法。方法:用2.4-二氯酚参与Trinder反应建立了两点法,从标本用量和方法上进行改进,并进行方法学评价。结果:酶促反应时间短(10分钟);线性范围宽(0~100U/L);批内CV为2.2%~3.8%;日间CV为4.3%;Hb大于0.56g/L时呈正干扰,胆红素大于171.2μmol/L时呈负干扰;127例健康人血清ADA为20.5±4.57u/L(x±s),27例结核性胸腹水患者ADA为76.15±16.4U/L(x±s),而21例非结核性胸腹水患者ADA为22.70±11.70U/L,两组间有显著性差异。结论:本法线性范围宽,呈色稳定,重复性好,是结核性与非结核性胸腹水鉴别的特异指标。由于该法简便、快速、易于控制,可在教学单位及中小医院推广应用,具有一定价值。Objective:To establish a two-point assay for measuring body fluid adenosine deaminase(ADA)activity based on reported methods.Methods:Using 2,4-phenyldichloride instead of TBHBA in Trinders reaction,a new two-point assay for measuring ADA activity was established.The sample sige and procedure were modified and methodological evaluation of the assay was carried out.Results:The reaction was shortened to 10 min;the linearity sange was wide (0~100U/L);the CVs of within batch and day to day were 2.2%~3.8%and 4.3% respectively;the Hb level above 0.56g/L gave a positive interference and the bilirubin level reaching 171.2μmol/L gave a negative interference;ADA activity for normal subjects ( n =127)is 20.5±4.57U/L,for pleurad and peritoncal effusions of tuberculous patients( n =27)is 76.15±16.4U/Land for non tuber culouspatients ( n =21)is 22.70±11.70U/L( P <0.05).Conclusion:The new assay showed wide linearity,good recovery and stable colouration and is a specific indication for distinguishing tuberculous effusions from non-tuberculous effusions.The method is simple,rapid and easily to control.It is worthy to be populariged in teaching and in application in middle-siged and small hospitals.

关 键 词:腺苷脱氨酶 结核 胸水 腹水 

分 类 号:R446.1[医药卫生—诊断学] R561.3[医药卫生—临床医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象